Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:ARM
NasdaqGS:ARMSemiconductor

Arm’s First AI Data Center Chip Tests Lofty Valuation And Growth Story

Arm Holdings (NasdaqGS:ARM) has introduced its first in-house AI data center chip, the AGI CPU. The chip is designed for AI workloads in data centers and was developed with Meta as a lead partner. The move expands Arm’s role from licensing semiconductor IP to offering its own production silicon. The launch targets the growing demand for AI infrastructure across large technology platforms. Arm has long been known for designing energy efficient processor architectures that sit inside...
NYSE:UBER
NYSE:UBERTransportation

Uber And Ibotta Partnership Highlights Retail Media Potential For Investors

Uber Technologies (NYSE:UBER) has entered a multi year exclusive digital promotions partnership with Ibotta across the U.S. The agreement embeds personalized promotions and coupons into Uber Eats and is expected to extend across the Uber and Postmates apps. The partnership connects consumer packaged goods brands directly with shoppers at the point of purchase inside Uber’s delivery ecosystem. For Uber Technologies, this move fits directly into its push beyond ride hailing into grocery and...
BIT:REY
BIT:REYIT

Reply’s Push Into Agentic, Sovereign AI Could Be A Game Changer For Reply (BIT:REY)

In March 2026, Reply expanded its French footprint by integrating Wemanity Reply, Wewyse Reply, Wizards Reply and Glue Reply, while also advancing its focus on agentic AI, cloud modernisation, data and customer experience across end-to-end digital transformation projects. Coupled with a new Mistral AI partnership to deliver custom, sovereign generative AI solutions for highly regulated sectors, these moves deepen Reply’s role in complex, mission-critical AI deployments across Europe. We’ll...
NYSE:TEVA
NYSE:TEVAPharmaceuticals

How Investors May Respond To Teva (TEVA) Advancing TEV ‘325 In Biologics For Inflammatory Diseases

Biolojic Design recently announced that TEV ‘325, a multibody targeting IL-13 and TSLP for TH2-driven inflammatory diseases, achieved a preclinical milestone in its collaboration with Teva, triggering milestone payments and confirming Teva’s exclusive global development and commercialization rights. This milestone underscores Teva’s progress in innovative biologics, adding scientific and commercial depth to its inflammatory disease pipeline alongside its established generics and branded...
NYSE:EDU
NYSE:EDUConsumer Services

A Look At New Oriental Education & Technology Group (NYSE:EDU) Valuation After Recent Mixed Share Price Performance

Recent performance snapshot for New Oriental Education & Technology Group (EDU) New Oriental Education & Technology Group (NYSE:EDU) has attracted attention after a 2.2% move over the past day, set against mixed recent returns that include a 5.1% decline over the past month and a small gain over the past 3 months. See our latest analysis for New Oriental Education & Technology Group. That latest 2.2% daily share price gain comes after a softer patch, with a 30 day share price return of 5.1%...
NYSE:EPR
NYSE:EPRSpecialized REITs

Assessing EPR Properties (EPR) Valuation After Recent Share Price Pullback

Event context and recent share performance EPR Properties (EPR) has attracted investor attention after recent trading left the shares about 1.7% lower on the day and roughly 10% lower over the past week. Over the past month, the stock shows a decline of about 16%. The past 3 months and year to date have been comparatively steadier, with total return over the past year modestly positive. See our latest analysis for EPR Properties. The recent 16.1% 1 month share price decline has pulled...